How a Digital-first Mindset is Helping Emerging Biotechs Break Through

Nearly six in 10 life sciences product launches are now in specialty or rare disease categories.1 Emerging pharma companies in these therapeutic areas need to educate physicians about niche diseases and their more complex biochemical interactions. Yet 75% of physicians say they want to either maintain or increase the pandemic-driven shift to remote interactions with … Read more